https://www.zacks.com/stock/news/2195560/digital-initiatives-to-keep-femsa-fmx-stock-in-good-stride?cid=CS-ZC-FT-analyst_blog|rank_focused-2195560
Dec 08, 2023 - FEMSA (FMX) is well-placed for growth through investments in digital and technology-driven initiatives, and continued strength in OXXO Mexico and OXXO Gas.
zc:7421675295552946809
0
https://seekingalpha.com/article/4656849-s-and-p-500-new-all-time-highs-before-a-major-sell-off?source=feed
Dec 08, 2023 - The economy is currently in good shape, but there are signs that a recession may occur in the second half of 2024. Explore more details here.
0
sa:15568721902073210
0
https://www.zacks.com/stock/news/2195512/american-public-education-apei-now-trades-above-golden-cross-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2195512
Dec 08, 2023 - Is it a good or bad thing when a stock experiences a golden cross technical event?
zc:3770378503010848510
0
https://www.zacks.com/stock/news/2195513/ecolab-ecl-s-technical-outlook-is-bright-after-key-golden-cross?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2195513
Dec 08, 2023 - Is it a good or bad thing when a stock experiences a golden cross technical event?
zc:-5327723798326380927
0
https://www.fool.com/investing/2023/12/08/3-beautiful-new-reasons-to-buy-ulta-stock/?source=iedfolrf0000001
Dec 08, 2023 - The beauty products retailer had some good news for investors in its latest update.
0
fool:-26468137876106595
0
https://www.zacks.com/stock/news/2195418/wall-street-analysts-think-adma-biologics-adma-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2195418
Dec 08, 2023 - Based on the average brokerage recommendation (ABR), Adma Biologics (ADMA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
zc:-6633538458053763847
0
https://www.zacks.com/stock/news/2195427/adm-adm-is-considered-a-good-investment-by-brokers-is-that-true?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2195427
Dec 08, 2023 - According to the average brokerage recommendation (ABR), one should invest in ADM (ADM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
zc:-7593340810139551184
0
https://www.zacks.com/stock/news/2195431/vipshop-holdings-limited-vips-recently-broke-out-above-the-50-day-moving-average?cid=CS-ZC-FT-tale_of_the_tape|50_day_moving_average_(yseop)-2195431
Dec 08, 2023 - When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?
zc:-1153040025189251300
0
https://www.zacks.com/stock/news/2195361/what-makes-eyepoint-pharmaceuticals-eypt-a-good-fit-for-trend-investing?cid=CS-ZC-FT-tale_of_the_tape|recent_price_strength_screen-2195361
Dec 08, 2023 - If you are looking for stocks that are well positioned to maintain their recent uptrend, EyePoint Pharmaceuticals (EYPT) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
zc:-7699542714388067091
0
https://www.fool.com/investing/2023/12/07/everyone-is-talking-about-tilray-brands-stock/?source=iedfolrf0000001
Dec 07, 2023 - Tilray's shift into making alcohol means that the vision for its future is now a lot bigger.
0
fool:-2434793386607990134
0